Cytoplasmic thymidine kinase (TK1) is an enzyme closely related to DNA synthesis and cell proliferation. The activity and concentration of TK1 enzyme in resting cells of normal adults are extremely low. Once the cells become cancerous, the activity and concentration of TK1 will exceed the normal level by 2-100 times. Applying the thymidine kinase 1 developed by our company's patented technology
Diagnostic kit (chemiluminescence method) to detect the concentration of TK1 in serum will indicate the corresponding degree of cell proliferation in the body, which can be used to predict the occurrence and development of early tumors.
It is now quantitatively tracked and is one of the most advanced tumor cell proliferation markers in the world. Clinical studies have confirmed that TK1 is an important warning indicator for early detection of tumors. It is also an important indicator for clinical prognosis, treatment selection, and postoperative monitoring of tumors. It is also an important indicator for assessing the risk of recurrence and metastasis of tumor patients. Valid
One of the indicators.
Further examination to find out the primary tumor, early diagnosis and early treatment